Open trial of S-adenosylmethionine for treatment of depression. 1984

J F Lipinski, and B M Cohen, and F Frankenburg, and M Tohen, and C Waternaux, and R Altesman, and B Jones, and P Harris

Nine depressed inpatients completed trials with S-adenosylmethionine. Seven showed improvement or remission of their symptoms. As in European studies, no side effects were seen except the apparent induction of mania in two patients with bipolar disorder.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011569 Psychiatric Status Rating Scales Standardized procedures utilizing rating scales or interview schedules carried out by health personnel for evaluating the degree of mental illness. Factor Construct Rating Scales (FCRS),Katz Adjustment Scales,Lorr's Inpatient Multidimensional Psychiatric Rating Scale,Wittenborn Scales,Edinburgh Postnatal Depression Scale,Mini International Neuropsychiatric Interview
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D012436 S-Adenosylmethionine Physiologic methyl radical donor involved in enzymatic transmethylation reactions and present in all living organisms. It possesses anti-inflammatory activity and has been used in treatment of chronic liver disease. (From Merck, 11th ed) AdoMet,Ademetionine,FO-1561,Gumbaral,S Amet,S-Adenosyl-L-Methionine,S-Adenosylmethionine Sulfate Tosylate,SAM-e,Samyr,FO 1561,FO1561,S Adenosyl L Methionine,S Adenosylmethionine,S Adenosylmethionine Sulfate Tosylate

Related Publications

J F Lipinski, and B M Cohen, and F Frankenburg, and M Tohen, and C Waternaux, and R Altesman, and B Jones, and P Harris
September 1988, The American journal of psychiatry,
J F Lipinski, and B M Cohen, and F Frankenburg, and M Tohen, and C Waternaux, and R Altesman, and B Jones, and P Harris
January 1988, Neuroscience and biobehavioral reviews,
J F Lipinski, and B M Cohen, and F Frankenburg, and M Tohen, and C Waternaux, and R Altesman, and B Jones, and P Harris
April 2002, Australian family physician,
J F Lipinski, and B M Cohen, and F Frankenburg, and M Tohen, and C Waternaux, and R Altesman, and B Jones, and P Harris
June 2005, Clinical and investigative medicine. Medecine clinique et experimentale,
J F Lipinski, and B M Cohen, and F Frankenburg, and M Tohen, and C Waternaux, and R Altesman, and B Jones, and P Harris
December 1990, Journal of neurology, neurosurgery, and psychiatry,
J F Lipinski, and B M Cohen, and F Frankenburg, and M Tohen, and C Waternaux, and R Altesman, and B Jones, and P Harris
January 2020, Psychopharmacology,
J F Lipinski, and B M Cohen, and F Frankenburg, and M Tohen, and C Waternaux, and R Altesman, and B Jones, and P Harris
May 1990, The American journal of psychiatry,
J F Lipinski, and B M Cohen, and F Frankenburg, and M Tohen, and C Waternaux, and R Altesman, and B Jones, and P Harris
January 1994, Acta neurologica Scandinavica. Supplementum,
J F Lipinski, and B M Cohen, and F Frankenburg, and M Tohen, and C Waternaux, and R Altesman, and B Jones, and P Harris
July 1988, The Alabama journal of medical sciences,
J F Lipinski, and B M Cohen, and F Frankenburg, and M Tohen, and C Waternaux, and R Altesman, and B Jones, and P Harris
January 1986, International journal of clinical pharmacology research,
Copied contents to your clipboard!